The present study evaluates the synergistic effect of sulbactam/tazobactam in combination
with meropenem or colistin against multidrug resistant (MDR) Acinetobacter baumannii …

Abstract Purpose Nowadays, Acinetobacter baumannii is resistant to almost all available
antibiotics. The evaluation of synergistic effects between the antibiotics against this …

Background/aim: Acinetobacter baumannii (A. baumannii) is one of the most common
healthcare-associated infectious agents worldwide. The aim of this study was to investigate …

Objective: The aim of this study was to evaluate imipenem, meropenem, colistin, amikacin
and fosfomycin susceptibilities of multidrug resistant Acinetobacter baumannii clinical …

The increasing prevalence of multidrug-resistant and pan drug-resistant Acinetobacter
baumannii as a cause of nosocomial infections has led to the need for the reassessment of …

The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is
increasing worldwide and is leading to therapeutic problems. We investigated the in vitro …

Materials and Methods: In this prospective study, 29 patients with carbapenem resistance A.
baumannii ventilator-associated pneumonia were enrolled. Endotracheal aspirate …

Multidrug-resistant Acinetobacter baumannii (MDR-AB) is emerging as a major nosocomial
pathogen worldwide. In recent years, the inadequacy of antimicrobial agents available to …

Materials and Methods: A total 124 of A. baumannii isolates collected from clinical samples
of hospitalized patients which assessed for antibiotic susceptibility using disk diffusion …

Acinetobacter baumannii has emerged as a significant nosocomial pathogen, particularly in
intensive care units. Isolates of A. baumannii resistant to major groups of antibiotics have …